Cargando…

Ribavirin aerosol in hospitalized adults with respiratory distress and COVID‐19: An open‐label trial

There is an unmet medical need for effective treatments for hospitalized patients with coronavirus disease 2019 (COVID‐19). Ribavirin is a broad‐spectrum antiviral with demonstrated in vitro activity against multiple viruses, including severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poulakou, Garyfallia, Barakat, Maxime, Israel, Robert J., Bacci, Marcelo R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841304/ https://www.ncbi.nlm.nih.gov/pubmed/36326174 http://dx.doi.org/10.1111/cts.13436

Ejemplares similares

Ribavirin Aerosol in the Treatment of SARS-CoV-2: A Case Series
por: Messina, Emanuela, et al.
Publicado: (2021)

A randomized, placebo‐controlled study to evaluate safety and pharmacokinetics of inhaled ribavirin
por: Couroux, Peter, et al.
Publicado: (2022)

PEG interferon-α-2b/ribavirin: Interstitial pneumonitis and adult respiratory distress syndrome: case report
Publicado: (2013)

Aerosolized Surfactant for Preterm Infants with Respiratory Distress Syndrome
por: Brasher, Mandy, et al.
Publicado: (2021)

2640. Aerosol vs. Oral Ribavirin for the Treatment of Community-Acquired Respiratory Virus Infections in Lung Transplant Recipients
por: Mui, Emily, et al.
Publicado: (2019)

RIBAVIRIN AND RESPIRATORY SYNCYTIAL VIRUS
Publicado: (1986)

Target product profile: aerosolized surfactant for neonatal respiratory distress
por: Rao, Suman, et al.
Publicado: (2023)

An open label trial of anakinra to prevent respiratory failure in COVID-19
por: Kyriazopoulou, Evdoxia, et al.
Publicado: (2021)

Elimination of Aerosol Ribavirin Use in Immunocompromised Patients with Metapneumovirus and Parainfluenza Virus Infections
por: Mui, Emily, et al.
Publicado: (2017)

Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
por: Hung, Ivan Fan-Ngai, et al.
Publicado: (2020)

Efficacy and safety of sofosbuvir–velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial
por: Takehara, Tetsuo, et al.
Publicado: (2018)

The Aerogen(®) Solo Is an Alternative to the Small Particle Aerosol Generator (SPAG-2) for Administration of Inhaled Ribavirin
por: Dallas, Ronald H., et al.
Publicado: (2020)

Flow-controlled ventilation in moderate acute respiratory distress syndrome due to COVID-19: an open-label repeated-measures controlled trial
por: Van Dessel, Eleni D., et al.
Publicado: (2022)

Aerosol Delivery of Lung Surfactant and Nasal CPAP in the Treatment of Neonatal Respiratory Distress Syndrome
por: Walther, Frans J., et al.
Publicado: (2022)

1356. Ribavirin Use in Hospitalized Children
por: Otto, William R, et al.
Publicado: (2020)

Possible therapeutic effect of orally administered ribavirin for respiratory syncytial virus-induced acute respiratory distress syndrome in an immunocompetent patient: a case report
por: Yoon, Byung Woo, et al.
Publicado: (2017)

Effectiveness of Ribavirin and Corticosteroids for Severe Acute Respiratory Syndrome
por: Lau, Eric H.Y., et al.
Publicado: (2009)

Ribavirin
Publicado: (2016)

Ribavirin
por: Hall, Caroline Breese
Publicado: (1985)

Methylprednisolone in adults hospitalized with COVID-19 pneumonia: An open-label randomized trial (GLUCOCOVID)
por: Corral-Gudino, Luis, et al.
Publicado: (2021)

Neural underpinnings of open-label placebo effects in emotional distress
por: Schaefer, Michael, et al.
Publicado: (2022)

Efficacy of Curcuma longa in treatment of postprandial distress syndrome: An open-label randomized-controlled trial
por: Sawangroj, Nicharat, et al.
Publicado: (2019)

The adult respiratory distress syndrome.
por: Biondi, J. W., et al.
Publicado: (1986)

1600. An Optimal Respiratory Syncytial Virus (RSV) Treatment in Lung Transplant Recipients: Oral Ribavirin, Inhaled Ribavirin, or Conservative Approach
por: Permpalung, Nitipong, et al.
Publicado: (2018)

An Open-Label Trial of 12-Week Simeprevir plus Peginterferon/Ribavirin (PR) in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 1 (GT1)
por: Asselah, Tarik, et al.
Publicado: (2016)

Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial
por: Brendish, Nathan J, et al.
Publicado: (2017)

A retrospective analysis of clinical efficacy of ribavirin in adults hospitalized with severe COVID-19
por: Gong, Wei-Jing, et al.
Publicado: (2021)

Respiratory Syncytial Virus Infection Morbidity in the Elderly: Time for Repurposing of Ribavirin?
por: de Zwart, Auke E S, et al.
Publicado: (2020)

Successful Treatment of Respiratory Syncytial Virus Infection in an Immunocompromised Patient With Ribavirin
por: Mir, Wasey Ali Yadullahi, et al.
Publicado: (2021)

Grazoprevir/elbasvir in peginterferon alfa plus ribavirin experienced patients with chronic genotype 1 HCV/HIV co-infection: a non-randomized, open-label clinical trial
por: Lin, Yi-Chun, et al.
Publicado: (2019)

Lopinavir/ritonavir/ribavirin: Various toxicities following off-label treatment: case report
Publicado: (2020)

Acute respiratory distress syndrome (ARDS) after pressurized intraperitoneal aerosol chemotherapy with oxaliplatin: a case report
por: Thibaudeau, Emilie, et al.
Publicado: (2021)

Mycobacterial Aerosols and Respiratory Disease
por: Falkinham, Joseph O.
Publicado: (2003)

The aerodynamic behaviour of respiratory aerosols
por: Grosskopf, K
Publicado: (2011)

Propagation of Respiratory Aerosols by the Vuvuzela
por: Lai, Ka-Man, et al.
Publicado: (2011)

Discussion on “Opening pressures and atelectrauma in acute respiratory distress syndrome”
por: Dong, Meiling, et al.
Publicado: (2017)

Effects of ribavirin on the replication and genetic stability of porcine reproductive and respiratory syndrome virus
por: Khatun, Amina, et al.
Publicado: (2015)

Respiratory syncytial virus‐associated acute respiratory illness in adult non‐immunocompromised patients: Outcomes, determinants of outcomes, and the effect of oral ribavirin treatment
por: Wongsurakiat, Phunsup, et al.
Publicado: (2022)

Aerosol, chemical and physical properties of dry powder synthetic lung surfactant for noninvasive treatment of neonatal respiratory distress syndrome
por: Walther, Frans J., et al.
Publicado: (2021)

Once-daily dose regimen of ribavirin is interchangeable with a twice-daily dose regimen: randomized open clinical trial
por: Balk, Jiska M, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_rlt6gttq2nrp1ssco6p38dig8v